Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ABBV | PLTR |
|---|---|---|
| Price | $265.83 | $192.75 |
| Change today | ▲ 0.28% | ▲ 0.50% |
| Market cap | $469.75B | $463.19B |
| Return, 3 months | +14.0% | +69.8% |
| Return, year to date | +19.1% | +8.4% |
| Return, 1 year | +24.6% | +7.3% |
| P/E (TTM) | 75.1 | 164.7 |
| P/B | -79.1 | 47.4 |
| P/E percentile vs own 5y | 70th | 39th |
| Dividend yield | 2.54% | – |
| Revenue growth (YoY, latest qtr) | +10.2% | +92.8% |
| Net profit growth (YoY) | +284.3% | +224.4% |
| Gross margin | 71.5% | 84.8% |
| Operating margin | 33.9% | 42.8% |
| Net margin | 9.7% | 49.0% |
| Return on equity | – | 38.4% |
| Analyst target vs. price | +6.8% | +4.0% |
| Analyst buy share | 86% | 73% |
| RSI (14) | 64 | 66 |
| 30-day volatility | 21.1% | 47.1% |
| Max drawdown, 1 year | -17.3% | -48.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.